Skip to main content
. 2018 Jan 31;55(6):1–11. doi: 10.1136/jmedgenet-2017-105127

Figure 4.

Figure 4

Penetrance of clinical disease in proband and non-proband SDHD p.Pro81Leu mutation carriers versus all other SDHD mutation carriers with 95% CI marked. P values are for the log-rank test comparing the survival distributions of SDHD p.Pro81Leu and all other SDHD mutation carriers. HNPGL, head and neck paraganglioma; PPGL, phaeochromocytoma and paraganglioma.